coronary microvascular disease
Conditions
Interventions
Treatment group:Conventional treatment with the addition of the Lohengrin formula
Control group:Conventional treatment
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for coronary microvascular disease; (2) Meet the diagnostic criteria for the Chinese medicine syndrome of complex deficiency and wind movement; (3) Age between 18 and 75 years old; (4) Signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Combination of severe cardiac arrhythmia severe heart failure (LVEF <35%) liver kidney and haematopoietic system and other serious primary diseases (liver and kidney function-related indexes are greater than two times the normal value or more) or psychosis; (2) Malignant tumour; (3) Other types of diabetes mellitus except type 2 diabetes mellitus; (4) Uncontrolled severe hypertension (systolic blood pressure = 180mmHg or diastolic blood pressure = 110mmHg); (5) Pregnant women lactating women or women of childbearing age with reproductive requirements. (6) Concomitant inflammatory conditions including connective tissue diseases inflammatory arthritis and active infections; (7) Oral antibiotics glucocorticoids immunosuppressants etc; (8) Patients using other herbal medicines or participating in other clinical trials within the last two weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seattle Angina Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| TNF-a;Myocardial blood flow;ET-1;Chinese Medicine Points Scale;SF-36 Quality of Life Scale;IL-6;MACE;NO; | — |
Countries
China
Contacts
Public ContactTianli Li
China-Japan Friendship Hospital
Outcome results
None listed